In a split opinion in Athena Diagnostics Inc. v. Mayo Collaborative Services LLC, the U.S. Court of Appeals for the Federal Circuit this week upheld a lower court ruling invalidating patent claims covering methods for diagnosing neurological disorders, such as myasthenia gravis, by detecting antibodies to muscle-specific tyrosine kinase.